Sonidegib-[d4]

Ask supplier a question | View on supplier's website

Sonidegib-[d4] is a labelled form of Sonidegib. Sonidegib is an orally bioavailable small-molecule Smoothened (Smo) antagonist with potential antineoplastic activity. It was approved by the FDA for treating basal-cell carcinoma in July 2015.

Supplier	BOC Sciences
Product #	BLP-004259
Pricing	Inquire
Molecular Weight	489.52
Molecular Formula	C26H22D4F3N3O3

Feedback